Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSP #451 - The Clinical and Economic Impact of Olanzapine in the Treatment of Schizophrenia

NCT00007774 is registered in ClinicalTrials.gov with US Department of Veterans Affairs as lead sponsor.

NCT NCT00007774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00007774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSP #451 - The Clinical and Economic Impact of Olanzapine in the Treatment of Schizophrenia
Lead sponsor
US Department of Veterans Affairs
Phase
Phase 4
Overall status
Completed
Start date
March 31, 1998
Completion date
Not reported
Enrollment
600 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia